Suresh R. Kapadia
Boehringer Ingelheim
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Suresh R. Kapadia.
Journal of Organic Chemistry | 2010
Jon C. Lorenz; Carl A. Busacca; XuWu Feng; Nelu Grinberg; Nizar Haddad; Joe Johnson; Suresh R. Kapadia; Heewon Lee; Anjan Saha; Max Sarvestani; Earl Spinelli; Rich Varsolona; Xudong Wei; Xingzhong Zeng; Chris H. Senanayake
A potent reversible inhibitor of the cysteine protease cathepsin-S was prepared on large scale using a convergent synthetic route, free of chromatography and cryogenics. Late-stage peptide coupling of a chiral urea acid fragment with a functionalized aminonitrile was employed to prepare the target, using 2-hydroxypyridine as a robust, nonexplosive replacement for HOBT. The two key intermediates were prepared using a modified Strecker reaction for the aminonitrile and a phosphonation-olefination-rhodium-catalyzed asymmetric hydrogenation sequence for the urea. A palladium-catalyzed vinyl transfer coupled with a Claisen reaction was used to produce the aldehyde required for the side chain. Key scale up issues, safety calorimetry, and optimization of all steps for multikilogram production are discussed.
Tetrahedron Letters | 1995
Denice M. Spero; Suresh R. Kapadia; Vittorio Farina
A new approach to the BOC-protected amino diol 1a via the opening of 3,4-cis-disubstituted β-lactam 3 with isobutylmagnesium chloride is described. Nonracemic β-lactam 3 could be obtained by enzymatic resolution of the 3-acetoxy-β-lactam 4 or from a chiral precursor, methyl (R)-(−)-mandelate.
Tetrahedron Letters | 2002
Roger J. Snow; Tanja Butz; Abdelhakim Hammach; Suresh R. Kapadia; Tina Marie Morwick; Anthony S. Prokopowicz; Hidenori Takahashi; Jonathan Tan; Matt Aaron Tschantz; Xiao-Jun Wang
Abstract Reaction of 2-chlorobenzonitriles with β-ketoesters in an S N Ar reaction, followed by cyclization in acid provides a versatile route to isoquinolones. Starting from 2,6-dichloro-3-nitrobenzonitrile 7 , sequential displacement of the chlorines by an amine and a β-ketoester leads to imidazo[4,5- h ]isoquinolin-9-ones 1 , a new class of kinase inhibitor.
Journal of Chromatography A | 1994
Deborah E.H. Palladino; Jerry L. Hopkins; Richard H. Ingraham; Thomas C. Warren; Suresh R. Kapadia; Glenn J. Van Moffaert; Peter M. Grob; James M. Stevenson; Kenneth A. Cohen
Nevirapine (BI-RG-587) is a potent inhibitor of the polymerase activity of reverse transcriptase of human immunodeficiency virus type-1. Nevirapine, as well as several other non-nucleoside compounds of various structural classes, bind strongly at a site which includes tyrosines 181 and 188 of the p66 subunit of reverse transcriptase. The chromatography which was utilized to explore this binding site is described. BI-RH-448 and BI-RJ-70, two tritiated photoaffinity azido analogues of nevirapine, are each crosslinked to reverse transcriptase. The use of several HPLC-based techniques employing different modes of detection makes it possible to demonstrate a dramatic difference between the two azido analogues in crosslinking behavior. In particular, by comparing HPLC tryptic peptide maps of the photoadducts formed between reverse transcriptase and each azido analogue, it can be shown that crosslinking with BI-RJ-70 but not with BI-RH-448 is more localized, stable, and hence exploitable for the identification of the specifically bonded amino acid residue(s). In addition, comparison of the tryptic maps also makes it feasible to assess which rings of the nevirapine structure are proximal or distal to amino acid side chains of reverse transcriptase. Finally, another feature of the HPLC peptide maps is the application of on-line detection by second order derivative UV absorbance spectroscopy to identify the crosslinked amino acid residue.
Journal of Organic Chemistry | 1994
Vittorio Farina; Suresh R. Kapadia; Bala Krishnan; Chenjie Wang; Lanny S. Liebeskind
Journal of Medicinal Chemistry | 1991
Karl D. Hargrave; John R. Proudfoot; Karl G. Grozinger; Ernest Cullen; Suresh R. Kapadia; Usha R. Patel; Victor Fuchs; Scott C. Mauldin; Jana Vitous; Mark L. Behnke; Janice M. Klunder; Kollol Pal; Jerry W. Skiles; Daniel W. McNeil; Janice M. Rose; Grace C. Chow; Mark T. Skoog; Joe C. Wu; Gunther Schmidt; Wolfhard Engel; Wolfgang Eberlein; Tracy D. Saboe; Scot Campbell; Alan S. Rosenthal; Julian Adams
Journal of Medicinal Chemistry | 2002
Roger J. Snow; Mario G. Cardozo; Tina Morwick; Carl A. Busacca; Yong Dong; Robert J. Eckner; Stephen P. Jacober; Scott Jakes; Suresh R. Kapadia; Susan Lukas; Maret Panzenbeck; Gregory W. Peet; Jeffrey D. Peterson; Anthony S. Prokopowicz; Rosemarie Sellati; Robert M. Tolbert; Matt Aaron Tschantz; Neil Moss
Archive | 2005
Carl A. Busacca; Rogelio P. Frutos; Nizar Haddad; Suresh R. Kapadia; Jon C. Lorenz; Anjan Saha; Chris H. Senanayake; Xudong Wei
Journal of Medicinal Chemistry | 2003
Daniel R. Goldberg; Tanja Butz; Mario G. Cardozo; Robert J. Eckner; Abdelhakim Hammach; Jessica Huang; Scott Jakes; Suresh R. Kapadia; Mohammed A. Kashem; Susan Lukas; Tina Morwick; Maret Panzenbeck; Usha R. Patel; Susan Pav; Gregory W. Peet; Jeffrey D. Peterson; Anthony S. Prokopowicz; Roger J. Snow; Rosemarie Sellati; Hidenori Takahashi; Jonathan Tan; Matt Aaron Tschantz; Xiao-Jun Wang; Yong Wang; John P. Wolak; Pla Xiong; Neil Moss
Archive | 2002
Suresh R. Kapadia; Jinhua J. Song; Nathan K. Yee